|
VOLUME 33: NO. 9 SEPTEMBER 2006
Editorials
Lupus and Thrombosis
 
D. Erkan .........1715
Depression and Employment Among People with Arthritis
S. Reisine .........1718
Arthritis, Continuing Medical Education, and Oil Sand: Changes in Market Forces Can Alter Perceptions of an Underutilized Resource
S.A. Mazzuca .........1721
Dyspnea Due to Pulmonary Hypertension and Interstitial Lung Disease in Scleroderma: Room for Improvement in Diagnosis and Management
H. Racz, S. Mehta .........1723
Articles
Intranasal Administration of Recombinant Human Cartilage Glycoprotein-39. A Phase I Escalating Cohort Study in Patients with RA
M.M. Zandbelt, J.G.A. Houbiers, F.H.J. van den Hoogen, et al .........1726
Insufficient Endogenous Control of TNF-α Contributes to TMJ Pain and Tissue Destruction in RA
P. Alstergren, S. Kopp .........1734
Mortality in Patients with RA Treated with Low-Dose Oral Glucocorticoids. A Population-Based Cohort Study
S. Sihvonen, M. Korpela, J. Mustonen, et al .........1740
Using Predicted Disease Outcome to Provide Differentiated Treatment of Early RA
J. de Vries-Bouwstra, S. Le Cessie, C. Allaart, F. Breedveld, T. Huizinga .........1747
Plasma Level of CXC-Chemokine CXCL12 Is Increased in RA and Is Independent of Disease Activity and MTX Treatment
I. Hansen, T. Ellingsen, N. Hornung, J.H. Poulsen, T. Lottenburger, K. Stengaard-Pedersen .........1754
MRI of the Hand for the Diagnosis of RA in the Absence of Anti-CCP Antibodies: A Prospective Study
E. Solau-Gervais, J-L. Legrand, B. Cortet, B. Duquesnoy, R-M. Flipo .........1760
Indications for Lowering LDL Cholesterol in RA: An Unrecognized Problem
M. Soubrier, D. Zerkak, M. Dougados .........1766
Hospitalization and Mortality of Patients with SLE
E. Krishnan .........1770
Anti-β2-GPI: Prevalence, Clinical Correlations, and Importance of Persistent Positivity in Patients with APS and SLE
A. Danowski, T.S. Kickler, M. Petri .........1775
Risk for Incident Arterial or Venous Vascular Events Varies Over the Course of SLE
E.R. Chang, C.A. Pineau, S. Bernatsky, C. Neville, A.E. Clarke, P.R. Fortin .........1780
Anti-dsDNA Antibody Testing by Farr and ELISA Techniques Is Not Equivalent
T. Neogi, D.D. Gladman, D. Ibanez, M. Urowitz .........1785
HRCT in Fibrosing Alveolitis Associated with SSc
D. Launay, M. Remy-Jardin, U. Michon-Pasturel, et al .........1789
Use of Etanercept in the Treatment of DM: A Case Series
F. Iannone, C. Scioscia, P.C.F. Falappone, M. Covelli, G. Lapadula .........1802
Celecoxib Is Efficacious and Well Tolerated in Treating Signs and Symptoms of AS
A. Barkhuizen, S. Steinfeld, J. Robbins, C. West, J. Coombs, S. Zwillich .........1805
Characteristics of Chronic Gout in Northern Sulawesi, Indonesia
C. Padang, K.D. Muirden, H.R. Schumacher, J. Darmawan, A.R. Nasution .........1813
Chondrocyte Death Induced by Pathological Concentration of Chemokine Stromal Cell-Derived Factor-1
L. Wei, X. Sun, K. Kanbe, et al ......... 1818
Effects of Training on General Practitioners' Management of Pain in OA: A Randomized Multicenter Study
O. Chassany, F. Boureau, F. Liard, et al .........1827
The Relationship Between Prospectively Assessed Body Weight and Physical Activity and Prevalence of Radiological Knee OA in Postmenopausal Women
C. Szoeke, L. Dennerstein, J. Guthrie, M. Clark, F.M. Cicuttini .........1835
Longterm Efficacy of Topical NSAID in Knee OA: Metaanalysis of Randomized Placebo Controlled Clinical Trials
S. Biswal, B. Medhi, P. Pandhi .........1841
The Relationship Between the Knee Adduction Moment and Knee Pain in Middle-aged Women Without Radiographic OA
A.J. Teichtahl, A.E. Wluka, M.E. Morris, S.R. Davis, F.M. Cicuttini .........1845
Workplace, Psychosocial Factors, and Depressive Symptoms Among Working People with Arthritis: A Longitudinal Study
X. Li, M.A.M. Gignac, A.H. Anis .........1849
Revisiting Arthritis Prevalence Projections — It’s More Than Just the Aging of the Population
A.V. Perruccio, J.D. Power, E.M. Badley .........1856
Sleep Quality in Patients with FM Using the Pittsburgh Sleep Quality Index
C.D. Osorio, A.L. Gallinaro, G. Lorenzi-Filho, L.V. Lage .........1863
In Memoriam Charles W. Denko, PhD, MD, 1916-2005
C.J. Malemud .........1866
Pediatric Rheumatology
Is There a Role for Arthroscopic Synovectomy in Oligoarticular JIA?
M.M. Martinez Toledo, G. Martini, C. Gigante, L. Da Dalt, A. Tregnaghi, F. Zulian .........1868
Neuropsychiatric Manifestations in Pediatric SLE and Association with Antiphospholipid Antibodies
L. Harel, C. Sandborg, T. Lee, E. von Scheven .........1873
Case Reports
Therapy with G-CSF in SLE May Be Associated with Severe Flares
I.M. Vasiliu, M.A. Petri, A.N. Baer .........1878
Monitoring Oral Anticoagulation May Require Determination of Single Coagulation Factor Activities in Patients with APS
C. Sucker, F. Wenzel, R.B. Zotz, G.R. Hetzel, R.E. Scharf .........1881
Extracranial Meningioma Presenting as a Neck Mass in a Patient with Underlying AS
T. Galm, F. MacGregor, A-M. Sinclair, J. Hunter, A. McPhaden .........1883
ANCA-Positive Crescentic Glomerulonephritis in Scleroderma — A Different Kind of Renal Crisis
D.L. Kamen, F.M. Wigley, A.N. Brown .........1886
Images in Rheumatology
Pathologic Fracture of the Hip Due to Severe Gouty Arthritis
T.A. Bates, J.B. Renner, B.L. Jonas .........1889
Care III Conference
Setting Priorities in Arthritis Care
Toronto, Canada, May 2, 2006
Introduction Setting Priorities in Arthritis Care: Care III Conference
L.C. Li, C. Bombardier .........1891
Team Care. Traditions and New Trends
I.F. Petersson .........1895
Does Everybody Need a Team?
T.P.M. Vliet Vlieland, L.C. Li, C. MacKay, E.M. Badley .........1897
Current Topics on Models of Care in the Management of Inflammatory Arthritis
T.P.M. Vliet Vlieland, L.C. Li, C. MacKay, C. Bombardier, E.M. Badley .........1900
Design Issues and Priorities in Team and Nonpharmacological Arthritis Care Research
M.D. Iversen, I.F. Petersson .........1904
Outcome Measures for Arthritis Care Research: Recommendations from the Care III Conference
C.L. Backman .........1908
Correspondence
Intraarticular Injection of Infliximab
G.T. Sakellariou, G. Kakavouli, I. Chatzigiannis .........1912
Reply
L. Schatteman .........1913
Seasonal Variation of Primary Neuropsychiatric SLE
G.M. Steup-Beekman, B.M.A. Gahrmann, S.C.A. Steens, M.A. van Buchem, T.W.J. Huizinga .........1913
Reply
N. Schlesinger ......... 1914
Bosentan Improves Functional Class, Pulmonary Artery Systolic Pressure, and DLCO in Scleroderma Patients with Pulmonary Hypertension: A Possible Synergy with Iloprost
L. Beretta, R. Scorza, N. Del Papa, A. Mazzone .........1915
Reply
D.J. Riley, D.A. McCloskey, J.A. Wilson, J.R. Seibold .........1916
Leflunomide for Relapsing Polychondritis: Successful Longterm Treatment
R.P. Handler .........1916
Reply
J.L. Abruzzo .........1916
Letters
Infliximab-Associated Pneumonitis in RA
J. Hennum, J. Nace, E. Shammash, E. Gertner .........1917
Thermographic and Symptomatic Effect of a Single Dose of Sildenafil Citrate on Raynaud’s Phenomenon in Patients with SSc: A Potential Treatment
N. Kumar, B. Griffiths, J. Allen .........1918
Patients Know It: Hughes Syndrome Is Unique
E. Rosenthal, R. Foster, S. Sangle, D. D'Cruz ......... 1919
Meetings in Rheumatology
|
